Fetal Neurobehavioral Development in Methadone Maintained Pregnancies
NCT00067184 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 157
Last updated 2018-04-25
Summary
The purpose of this study is to examine differences in fetal neurobehavior at peak (2 hours after oral dose) vs. trough (2 hours before oral dose) maternal plasma methadone levels.
Conditions
- Opioid-Related Disorders
Interventions
- DEVICE
-
Toitu 320/325
Fetal monitor
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
collaborator NIH - lead OTHER
Principal Investigators
-
Lauren M. Jansson, M.D. · Johns Hopkins University
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-09-30
- Primary Completion
- 2010-08-31
- Completion
- 2010-08-31
Countries
- United States
Study Locations
More Related Trials
-
Maternal Opioid Treatment: Human Experimental Research - Data Yield Appropriate Decisions
NCT04049799 ·Status: COMPLETED
-
Utility of Psychosocial Intervention in Improving Outcome for Methadone-exposed Infants and Their Mothers
NCT01889121 ·Status: COMPLETED
-
Tobacco Use in Opioid Agonist Treated Pregnant Women
NCT00497068 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Predicting and Preventing Adverse Maternal and Child Outcomes of Opioid Use Disorder in Pregnancy
NCT05942313 ·Status: RECRUITING
-
Comparison of Buprenorphine and Methadone - 3
NCT00000334 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating a Novel Medication Device for Methadone Dosing
NCT03254043 ·Status: COMPLETED ·Phase: NA
-
Methadone Levels in Breast Milk of Women Taking Methadone for Opiate Addiction - 2
NCT00218010 ·Status: COMPLETED
-
RCT of High- vs. Standard-Calorie Formula for Methadone-Exposed Infants
NCT02178189 ·Status: COMPLETED ·Phase: PHASE2
-
Medication Treatment for Opioid Use Disorder in Expectant Mothers: Conceptual Model Assessments Sub-study
NCT03911466 ·Status: COMPLETED
-
Entry Into Comprehensive Methadone Treatment Via Interim Maintenance
NCT00712036 ·Status: COMPLETED ·Phase: NA
-
Buprenorphine Maintenance for Opioid-Addicted Persons in Jail and Post-Release
NCT00367302 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effects of Buprenorphine/Naloxone in Treating Opioid Dependent Individuals Who Are Maintained on Methadone
NCT00000243 ·Status: TERMINATED ·Phase: NA
-
Opioid Dependence Treatment Therapies in Pregnancy
NCT03098407 ·Status: COMPLETED ·Phase: NA
-
Technology-Enhanced Therapy vs. Medication Monitoring for Buprenorphine Retention in Pregnant Persons
NCT06999811 ·Status: RECRUITING ·Phase: NA
-
Open Trial of Technology-Enhanced Behavioral Intervention for Buprenorphine Retention in Pregnant and Postpartum People
NCT06496230 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Reinforcement-Based Treatment for Pregnant Drug Abusers
NCT01177982 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts - 1
NCT00000216 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of Methadone and Buprenorphine in Interstitial Fluid
NCT05546229 ·Status: COMPLETED
-
Treating the Partners of Drug Using Pregnant Women: Stage II
NCT00496990 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Assessing a Clinically-meaningful Opioid Withdrawal Phenotype
NCT05027919 ·Status: RECRUITING ·Phase: PHASE2
-
Study of LYN-014 in Individuals With Opioid Use Disorder Who Are Stable on Methadone Therapy
NCT05251376 ·Status: WITHDRAWN ·Phase: PHASE1
-
Piloting a Web Resource for Pregnancy OUD in Jail
NCT05853289 ·Status: COMPLETED ·Phase: NA
-
Maternal Brain Imaging in Opioid Use Disorder
NCT06008990 ·Status: COMPLETED
-
Drug Interaction & Methadone & Buprenorphine
NCT02045693 ·Status: COMPLETED ·Phase: PHASE1
-
A Bridge to Treatment: The Therapeutic Workplace and Methadone Treatment
NCT01416584 ·Status: COMPLETED ·Phase: NA